1. Home
  2. NTHI vs MRAM Comparison

NTHI vs MRAM Comparison

Compare NTHI & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • MRAM
  • Stock Information
  • Founded
  • NTHI 2008
  • MRAM 2008
  • Country
  • NTHI United States
  • MRAM United States
  • Employees
  • NTHI N/A
  • MRAM N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • MRAM Semiconductors
  • Sector
  • NTHI Health Care
  • MRAM Technology
  • Exchange
  • NTHI Nasdaq
  • MRAM Nasdaq
  • Market Cap
  • NTHI 155.4M
  • MRAM 150.5M
  • IPO Year
  • NTHI N/A
  • MRAM 2016
  • Fundamental
  • Price
  • NTHI $11.00
  • MRAM $8.07
  • Analyst Decision
  • NTHI
  • MRAM Strong Buy
  • Analyst Count
  • NTHI 0
  • MRAM 1
  • Target Price
  • NTHI N/A
  • MRAM $8.00
  • AVG Volume (30 Days)
  • NTHI 87.3K
  • MRAM 111.0K
  • Earning Date
  • NTHI 08-19-2025
  • MRAM 10-29-2025
  • Dividend Yield
  • NTHI N/A
  • MRAM N/A
  • EPS Growth
  • NTHI N/A
  • MRAM 2.00
  • EPS
  • NTHI N/A
  • MRAM 0.07
  • Revenue
  • NTHI $59,990.00
  • MRAM $51,675,000.00
  • Revenue This Year
  • NTHI N/A
  • MRAM $10.80
  • Revenue Next Year
  • NTHI N/A
  • MRAM $13.42
  • P/E Ratio
  • NTHI N/A
  • MRAM $105.93
  • Revenue Growth
  • NTHI N/A
  • MRAM N/A
  • 52 Week Low
  • NTHI $3.20
  • MRAM $4.34
  • 52 Week High
  • NTHI $25.00
  • MRAM $8.10
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • MRAM 80.50
  • Support Level
  • NTHI N/A
  • MRAM $6.20
  • Resistance Level
  • NTHI N/A
  • MRAM $6.99
  • Average True Range (ATR)
  • NTHI 0.00
  • MRAM 0.31
  • MACD
  • NTHI 0.00
  • MRAM 0.17
  • Stochastic Oscillator
  • NTHI 0.00
  • MRAM 99.49

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

Share on Social Networks: